John Cox
CEO, President at Dyne Therapeutics, Inc. (DYN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $444K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Sep 8SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 5,658357,507 held (−2%) | $18.88 | $107K | -11.9% |
| Aug 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 4,986363,165 held (−1%) | $26.28 | $131K | -36.7% |
| Jun 17SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 2,683368,151 held (−1%) | $18.33 | $49K | -9.2% |
| May 14SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 3,311370,834 held (−1%) | $18.36 | $61K | -9.4% |
| Mar 6SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 2,732374,145 held (−1%) | $14.90 | $41K | +11.7% |
| Dec 5SEC | DYNDyne Therapeutics, Inc. | Sell Plan | 2,662196,877 held (−1%) | $20.72 | $55K | -19.7% |
- Sell
CEO, President John Cox sold $107K of DYN at $18.88 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John Cox sold $131K of DYN at $26.28 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John Cox sold $49K of DYN at $18.33 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John Cox sold $61K of DYN at $18.36 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John Cox sold $41K of DYN at $14.90 — pre-scheduled 10b5-1 plan sale.
- Sell
CEO, President John Cox sold $55K of DYN at $20.72 — pre-scheduled 10b5-1 plan sale.